JULIE D. KLAPSTEIN - Corporate Board Profile

AMEDISYS INC

Filing Date	Source Excerpt
2017-04-25	Ms. Klapstein was a past director for two public boards and has been a director for multiple private companies.
2018-04-25	Ms. Klapstein serves on the board of directors for Quality Systems, Inc. and other companies. The Compensation Committee is currently comprised of Nathaniel M. Zilkha (Chairman), Ms. Klapstein and others. The Nominating and Corporate Governance Committee is comprised of Richard A. Lechleiter (Chairman) and each of our other independent directors including Ms. Klapstein. The Quality of Care Committee is comprised of Bruce D. Perkins (Chairman), Ms. Hall, Ms. Klapstein and Dr. Rideout. During 2017, all non-employee directors received a monthly retainer of $6,250 and per diem attendance fees. The Chairman of the Compensation Committee received an annual retainer of $15,000, the Chairman of the Nominating and Corporate Governance Committee received $10,000, and the Chairman of the Quality of Care Committee received $10,000. On June 8, 2017, each non-employee director received an equity grant valued at $150,000. Julie D. Klapstein total compensation was $259,032.
2019-04-26	Julie D. Klapstein was the founding Chief Executive Officer of Availity, LLC... Ms. Klapstein has outside board experience on three public company boards... Chair of Compensation Committee... received $121,667 fees and $150,046 stock awards totaling $271,713.
2020-04-24	Ms. Klapstein was the founding Chief Executive Officer of Availity, LLC, one of the nations largest health information networks optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. ... The Compensation Committee is currently comprised of Ms. Klapstein (Chair), Mses. Capps and Kline and Messrs. Netterville, Lechleiter and Washburn. ... The Nominating and Corporate Governance Committee is comprised of Richard A. Lechleiter (Chairman) and each of our other independent directors (Mses. Capps, Klapstein and Kline, Messrs. Netterville, Perkins and Washburn, Drs. Coye and Rideout). ... The Quality of Care Committee is currently comprised of Jeffrey A. Rideout, MD (Chairman), Dr. Coye, Ms. Klapstein and Mr. Perkins. ... During 2019, all non-employee directors received a monthly retainer of $6,250 and per diem attendance fees of $2,000 per each Board of Directors meeting and each committee meeting attended in person and $1,000 per diem attendance fees for each Board of Directors meeting and each committee meeting attended via teleconference. ... The following table shows the value of all cash and equity-based compensation paid to the members of our Board of Directors during the year ended December 31, 2019. ... Julie D. Klapstein Fees Earned or Paid in Cash: $125,000, Stock Awards: $150,089, Total: $275,089.
2021-04-28	Julie D. Klapstein is Chair of the Compensation Committee and member of the Nominating and Corporate Governance Committee. ... Ms. Klapstein earned $266,133 in total compensation in 2020.
2022-04-27	Julie D. Klapstein is the Lead Director. ... The Compensation Committee is currently comprised of Teresa L. Kline (Chair), Vickie L. Capps, Julie D. Klapstein and Jeffrey A. Rideout, MD. ... The Nominating and Corporate Governance Committee is comprised of Molly J. Coye, MD (Chair), Teresa L. Kline, Ivanetta Davis Samuels and Julie D. Klapstein (ex officio). ... The Quality of Care Committee is currently comprised of Jeffrey A. Rideout, MD (Chair), Molly J. Coye, MD, Julie D. Klapstein and Ivanetta Davis Samuels. ... The following table shows the value of all cash and equity-based compensation paid to the members of our Board of Directors during the year ended December 31, 2021. Julie D. Klapstein: Fees Earned or Paid in Cash: $118,917; Stock Awards: $149,992; Total: $268,909.
2023-04-27	Julie D. Klapstein is Lead Director. The Compensation Committee is currently comprised of Teresa L. Kline (Chair), Vickie L. Capps, Julie D. Klapstein and Jeffrey A. Rideout, MD. The Nominating and Corporate Governance Committee is comprised of Molly J. Coye, MD (Chair), Teresa L. Kline, Ivanetta Davis Samuels and Julie D. Klapstein (ex officio). The Quality of Care Committee is currently comprised of Jeffrey A. Rideout, MD (Chair), Molly J. Coye, MD, Julie D. Klapstein and Ivanetta Davis Samuels. On June 9, 2022, each of Mses. Capps, Kline, Klapstein and Samuels, Drs. Coye and Rideout, and Mr. Perkins received an equity grant of RSUs valued at $150,000 in connection with their re-election as directors at the 2022 annual meeting of stockholders.
2024-12-10	Julie D. Klapstein was the founding Chief Executive Officer of Availity, LLC... Julie D. Klapstein has served as our independent Lead Director since February 2022. ... The Nominating and Corporate Governance Committee is comprised of Molly J. Coye, MD (Chair), Teresa L. Kline, Ivanetta Davis Samuels and Julie D. Klapstein (ex officio). ... The following table shows the value of all cash and equity-based compensation paid to the members of our Board of Directors during the year ended December 31, 2023. ... Julie D. Klapstein, Fees Earned or Paid in Cash $130,000, Stock Awards $152,621, Total $282,621.